Alberto Ortiz to Cardiovascular Diseases
This is a "connection" page, showing publications Alberto Ortiz has written about Cardiovascular Diseases.
Connection Strength
0.358
-
Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD). Toxins (Basel). 2018 06 12; 10(6).
Score: 0.124
-
Antidiuretic Hormone and Serum Osmolarity Physiology and Related Outcomes: What Is Old, What Is New, and What Is Unknown? J Clin Endocrinol Metab. 2019 11 01; 104(11):5406-5420.
Score: 0.034
-
The effect of chronic kidney disease on lipid metabolism. Int Urol Nephrol. 2019 Feb; 51(2):265-277.
Score: 0.032
-
Practical issues in clinical scenarios involving CKD patients requiring antithrombotic therapy in light of the 2017 ESC guideline recommendations. BMC Med. 2018 09 19; 16(1):158.
Score: 0.032
-
Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study). Cardiovasc Drugs Ther. 2018 06; 32(3):255-263.
Score: 0.031
-
Salt Intake and Immunity. Hypertension. 2018 07; 72(1):19-23.
Score: 0.031
-
Lipid Management in Chronic Kidney Disease: Systematic Review of PCSK9 Targeting. Drugs. 2018 Feb; 78(2):215-229.
Score: 0.030
-
Global Cardiovascular and Renal Outcomes of Reduced GFR. J Am Soc Nephrol. 2017 Jul; 28(7):2167-2179.
Score: 0.029
-
Lipid management in patients with chronic kidney disease. Nat Rev Nephrol. 2018 12; 14(12):727-749.
Score: 0.008
-
Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease. Nutrients. 2017 May 12; 9(5).
Score: 0.007